Drug consumption in Ukraine is significantly lower than in EU countries. If one Ukrainian spends an average of USD 73 for drugs per year, then, for example, an Estonian spends USD 258, and a Swede spends USD 509.
The fact is that Ukrainian citizens buy 99% of drugs for their own money. While in the West most drug costs are covered by insurance and special state programs. The launch of such programs in Ukraine can provide the impetus for the market.
According to the CF "Patients of Ukraine", only 20% of citizens in case of illness turn to a family doctor or therapist, 32% are self-treated with drugs, 20% with folk remedies, 6% are consulted by a pharmacist or chemist.
On a positive note, Ukrainians began to buy more prescription drugs, which implies the involvement of a doctor in the medicine choice.
According to Proxima Research, over ten years, the ratio of prescription and non-prescription drugs in the Ukrainian consumer basket has become almost the opposite: if in 2008 it was 33% and 67% in physical terms, in 2018 it was 60% and 40%, respectively.
Since 2017, the state covers part of the expenses of Ukrainians for drugs. The program "Available drugs" includes 23 names of drugs for cardiovascular diseases, diabetes and bronchial asthma.
In the first year of the program, UAH 627 million was allocated, and in 2018 – more than UAH 1 billion. As a result, the consumption of drugs, the cost of which is reimbursed by the state, increased by 65% in the very first year, and by 36% in the next year.
State participation in procurement and reimbursement of drug costs is one of the drivers of growth in the domestic market. Medical reform implies, in general, to allocate 5% of GDP from the state budget to healthcare. Last year, this indicator was about 4%.